The global dental bone grafts substitutes market size was USD 812.60 million in 2023, estimated at USD 890.04 million in 2024 and is anticipated to reach around USD 2,184.84 million by 2034, expanding at a CAGR of 9.40% from 2024 to 2034.
The global dental bone grafts substitutes market size accounted for USD 890.04 million in 2024 and is predicted to reach around USD 2,184.84 million by 2034, growing a notable CAGR of 9.40% from 2024 to 2034. The North America dental bone grafts substitutes market size reached USD 316.91 million in 2023. Increasing the use of bone grafts in density and a growing number of dental implant surgeries are propelling the revenue.
Access our Healthcare Data Intelligence Tool with 10000+ Database, Visit: Towards Healthcare
The U.S. dental bone grafts substitutes market size was valued at USD 221.84 million in 2023 and is expected to be worth around USD 601.57 million by 2034, at a CAGR of 9.48% from 2024 to 2034.
North America dominated the global dental bone grafts substitutes market in 2023. This was propelled by factors such as a growing population in need of dental implants and increasing awareness of advanced dental products. Moreover, factors like rising healthcare expenses and the accessibility of advanced healthcare facilities contributed to the region's growth. Additionally, the increasing prevalence of dental diseases played a significant role in driving market expansion.
Asia Pacific is projected to experience the highest growth during the forecast period. This growth can be attributed to factors such as the increasing popularity of medical tourism and government initiatives. Furthermore, the region's aging population is contributing to a higher risk of dental issues. However, stringent regulatory guidelines in some countries may limit growth opportunities. In South Korea, products must be approved by the Korean Food and Drug Administration before being marketed, while in Australia, graft products are regulated by the Therapeutic Goods Administration. These strict regulations pose challenges for foreign players looking to enter the market.
Dental bone grafts create new bone that acts as a reservoir for minerals. Various substitutes for dental bone grafts include materials like bio-Oss, which is derived from bovine bone and like human bone, ceramic-based substitutes like calcium sulfate, and polymer-based substitutes like Healos. Synthetic bone grafts use materials like hydroxyapatite to mimic the mechanical properties of bone and facilitate bone growth for dental implants. Most studies use either allografts or xenografts as bone substitutes, which can be demineralized or mineralized freeze-dried bone allografts. Biomaterials used in dentistry include bone grafts and barrier membranes. The advancement of technology in biomaterials, driven by initiatives from key players and novel product launches, is expected to propel the dental bone grafts substitutes market.
Report Coverage | Details |
Growth Rate from 2024 to 2034 | CAGR of 9.40% |
Global Market Size in 2023 | USD 812.60 Million |
Global Market Size in 2024 | USD 890.04 Million |
Global Market Size by 2034 | USD 2184.84 Million |
Largest Market | North America |
Base Year | 2023 |
Forecast Period | 2024 to 2034 |
Segments Covered | Material Type, Application, End-user, and Region |
Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Growing prevalence of dental disorders
Many oral health issues, like gum disease, tooth loss, tooth decay, and oral cancers, are largely preventable and can be treated, especially when addressed early in life. Factors such as inadequate fluoride exposure, easy access to sugary foods, and limited access to dental care contribute to these conditions. Moreover, conditions like orofacial clefts, Noma, and dental trauma are of significant public health concern. Consumption of sugary foods and drinks, tobacco and alcohol, further exacerbates oral health problems and other non-communicable diseases. This increasing prevalence of dental disorders is expected to drive the demand for the dental bone grafts substitutes market.
Expensive method of treatment
Bone grafts and substitute procedures can be costly, which may make them inaccessible to some patients, hence can limit the market growth. Certain healthcare systems have restrictive reimbursement policies for these procedures, making it challenging for patients, especially those with inadequate insurance coverage, to afford them. Furthermore, potential risks like infection, rejection, and nerve damage associated with these procedures also hinder the dental bone grafts substitutes market expansion.
Lucrative opportunities in developing countries
The dental bone grafts substitutes market is poised for growth, especially in emerging economies, driven by factors like improved healthcare infrastructure, rising demand for bone grafting procedures, and increasing prevalence of spinal disorders. Emerging economies are witnessing significant development in their healthcare sectors, fueled by government investments and the rise of medical tourism. This trend isn't limited to developed nations; countries like China, Brazil, and India are also experiencing a surge in demand for bone grafts and substitutes. Globally, there's a rising incidence of bone disorders such as osteoporosis and bone cancer, driving the need for these treatments to alleviate associated symptoms, which can create market opportunities in the future.
The xenograft product segment dominated the dental bone grafts substitutes market in 2023. Xenografts, sourced from pigs or cows, undergo sterilization and meticulous preparation before being implanted into humans. In dentistry, deproteinized bovine bone is commonly used for xenograft materials. Additionally, strategic initiatives by market players are contributing to the market's growth.
In the dental bone grafts substitutes market, the synthetic segment is expected to grow at the fastest rate over the forecast period. The growth of synthetic grafts can be credited to their superior osteoconductive, hardness, and higher acceptance rates. In the market, there are several types of synthetic materials available, including ceramic, polymer-based, and BMPs (bone morphogenetic proteins). Synthetic grafting carries a lower risk of disease transmission compared to xenografts and allografts, which further enhances its growth. There's a rising demand to develop biocompatible grafts to minimize adverse reactions, which is propelling this segment's expansion.
The socket preservation segment dominated the dental bone grafts substitutes market in 2023. This method aims to reduce bone loss that occurs after tooth extraction by filling the socket in the jawbone. The segment is growing due to the rising number of dental implant surgeries and increased awareness about oral health care among the population.
In the dental bone grafts substitutes market, the sinus lift segment is the fastest-growing segment during the projected period. This market is growing because more people are undergoing dental implant surgeries and becoming more aware of the significance of oral health care. Moreover, there's a growing burden of dental diseases, and advancements in dental technology are further fueling the growth of this segment.
The dental clinic segment dominated the dental bone grafts substitutes market in 2023. This segment's growth is driven by an increasing number of dental clinics and the growing occurrence of dental issues. Dental clinics are gaining popularity due to their convenience and the availability of skilled surgeons, leading to a rise in the number of dental graft surgeries performed annually.
The hospital segment is the fastest-growing segment during the studied period. Hospitals see many patients, some of whom need orthopedic and dental procedures involving bone graft substitutes. This demand is significant due to the diverse medical services hospitals provide, including surgeries. Procedures like spinal fusion, joint replacements, and dental implants are commonly performed in hospitals, contributing substantially to the market for dental bone graft substitutes.
Segments Covered in the Report
By Material Type
By Application
By End-user
By Geography
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Dental Bone Grafts Substitutes Market
5.1. COVID-19 Landscape: Dental Bone Grafts Substitutes Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Dental Bone Grafts Substitutes Market, By Material Type
8.1. Dental Bone Grafts Substitutes Market Revenue and Volume, by Material Type, 2024-2034
8.1.1 Autograft
8.1.1.1. Market Revenue and Volume Forecast (2021-2034)
8.1.2. Allograft
8.1.2.1. Market Revenue and Volume Forecast (2021-2034)
8.1.3. Demineralized Bone Matrix
8.1.3.1. Market Revenue and Volume Forecast (2021-2034)
8.1.4. Others
8.1.4.1. Market Revenue and Volume Forecast (2021-2034)
8.1.5. Xenograft
8.1.5.1. Market Revenue and Volume Forecast (2021-2034)
8.1.6. Synthetic
8.1.6.1. Market Revenue and Volume Forecast (2021-2034)
Chapter 9. Global Dental Bone Grafts Substitutes Market, By Application
9.1. Dental Bone Grafts Substitutes Market Revenue and Volume, by Application, 2024-2034
9.1.1. Ridge augmentation
9.1.1.1. Market Revenue and Volume Forecast (2021-2034)
9.1.2. Sinus lift
9.1.2.1. Market Revenue and Volume Forecast (2021-2034)
9.1.3. Periodontal defect regeneration
9.1.3.1. Market Revenue and Volume Forecast (2021-2034)
9.1.4. Implant bone regeneration
9.1.4.1. Market Revenue and Volume Forecast (2021-2034)
9.1.5. Socket preservation
9.1.5.1. Market Revenue and Volume Forecast (2021-2034)
Chapter 10. Global Dental Bone Grafts Substitutes Market, By End-user
10.1. Dental Bone Grafts Substitutes Market Revenue and Volume, by End-user, 2024-2034
10.1.1. Hospitals
10.1.1.1. Market Revenue and Volume Forecast (2021-2034)
10.1.2. Dental clinics
10.1.2.1. Market Revenue and Volume Forecast (2021-2034)
Chapter 11. Global Dental Bone Grafts Substitutes Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Volume Forecast, by Material Type (2021-2034)
11.1.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.1.3. Market Revenue and Volume Forecast, by End-user (2021-2034)
11.1.4. U.S.
11.1.4.1. Market Revenue and Volume Forecast, by Material Type (2021-2034)
11.1.4.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.1.4.3. Market Revenue and Volume Forecast, by End-user (2021-2034)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Volume Forecast, by Material Type (2021-2034)
11.1.5.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.1.5.3. Market Revenue and Volume Forecast, by End-user (2021-2034)
11.2. Europe
11.2.1. Market Revenue and Volume Forecast, by Material Type (2021-2034)
11.2.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.2.3. Market Revenue and Volume Forecast, by End-user (2021-2034)
11.2.4. UK
11.2.4.1. Market Revenue and Volume Forecast, by Material Type (2021-2034)
11.2.4.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.2.4.3. Market Revenue and Volume Forecast, by End-user (2021-2034)
11.2.5. Germany
11.2.5.1. Market Revenue and Volume Forecast, by Material Type (2021-2034)
11.2.5.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.2.5.3. Market Revenue and Volume Forecast, by End-user (2021-2034)
11.2.6. France
11.2.6.1. Market Revenue and Volume Forecast, by Material Type (2021-2034)
11.2.6.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.2.6.3. Market Revenue and Volume Forecast, by End-user (2021-2034)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Volume Forecast, by Material Type (2021-2034)
11.2.7.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.2.7.3. Market Revenue and Volume Forecast, by End-user (2021-2034)
11.3. APAC
11.3.1. Market Revenue and Volume Forecast, by Material Type (2021-2034)
11.3.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.3.3. Market Revenue and Volume Forecast, by End-user (2021-2034)
11.3.4. India
11.3.4.1. Market Revenue and Volume Forecast, by Material Type (2021-2034)
11.3.4.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.3.4.3. Market Revenue and Volume Forecast, by End-user (2021-2034)
11.3.5. China
11.3.5.1. Market Revenue and Volume Forecast, by Material Type (2021-2034)
11.3.5.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.3.5.3. Market Revenue and Volume Forecast, by End-user (2021-2034)
11.3.6. Japan
11.3.6.1. Market Revenue and Volume Forecast, by Material Type (2021-2034)
11.3.6.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.3.6.3. Market Revenue and Volume Forecast, by End-user (2021-2034)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Volume Forecast, by Material Type (2021-2034)
11.3.7.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.3.7.3. Market Revenue and Volume Forecast, by End-user (2021-2034)
11.4. MEA
11.4.1. Market Revenue and Volume Forecast, by Material Type (2021-2034)
11.4.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.4.3. Market Revenue and Volume Forecast, by End-user (2021-2034)
11.4.4. GCC
11.4.4.1. Market Revenue and Volume Forecast, by Material Type (2021-2034)
11.4.4.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.4.4.3. Market Revenue and Volume Forecast, by End-user (2021-2034)
11.4.5. North Africa
11.4.5.1. Market Revenue and Volume Forecast, by Material Type (2021-2034)
11.4.5.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.4.5.3. Market Revenue and Volume Forecast, by End-user (2021-2034)
11.4.6. South Africa
11.4.6.1. Market Revenue and Volume Forecast, by Material Type (2021-2034)
11.4.6.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.4.6.3. Market Revenue and Volume Forecast, by End-user (2021-2034)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Volume Forecast, by Material Type (2021-2034)
11.4.7.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.4.7.3. Market Revenue and Volume Forecast, by End-user (2021-2034)
11.5. Latin America
11.5.1. Market Revenue and Volume Forecast, by Material Type (2021-2034)
11.5.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.5.3. Market Revenue and Volume Forecast, by End-user (2021-2034)
11.5.4. Brazil
11.5.4.1. Market Revenue and Volume Forecast, by Material Type (2021-2034)
11.5.4.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.5.4.3. Market Revenue and Volume Forecast, by End-user (2021-2034)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Volume Forecast, by Material Type (2021-2034)
11.5.5.2. Market Revenue and Volume Forecast, by Application (2021-2034)
11.5.5.3. Market Revenue and Volume Forecast, by End-user (2021-2034)
Chapter 12. Company Profiles
12.1. Medtronic (U.S.)
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Stryker Corporation (U.S.)
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Johnson & Johnson (U.S.)
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Zimmer Biomet Holdings, Inc. (U.S.)
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Baxter International Inc. (U.S.)
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. NuVasive, Inc. (U.S.)
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Integra LifeSciences Corporation (U.S.)
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Wright Medical Group N.V. (Netherlands)
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Olympus Corporation (Japan)
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. RTI Surgical Holdings, Inc. (U.S.)
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client